Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: Follow-up from a randomized controlled trial

12Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

Background: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age. At 13 months of age, most of these children had pneumococcal serotype-specific IgG concentrations ≥0.35 μg/ml and opsonophagocytic assay (OPA) titers ≥8. Methods: Children who had participated in the original study were enrolled again at 3.5 years of age. Persistence of immunity following infant immunization with either PCV-7 or PCV-13 and the immune response to a PCV-13 booster at preschool age were investigated. Results: In total, 108 children were followed-up to the age of 3.5 years and received a PCV-13 booster at this age. At least 76% of children who received PCV-7 or PCV-13 in infancy retained serotype-specific IgG concentrations ≥0.35 μg/ml against each of 5/7 shared serotypes. For serotypes 4 and 18C, persistence was lower at 22-42%. At least 71% of PCV-13 group participants had IgG concentrations ≥0.35 μg/ml against each of 4/6 of the additional PCV-13 serotypes; for serotypes 1 and 3 this proportion was 45% and 52%. In the PCV-7 group these percentages were significantly lower for serotypes 1, 5 and 7F. A pre-school PCV-13 booster was highly immunogenic and resulted in low rates of local and systemic adverse effects. Conclusion: Despite some decline in antibody from 13 months of age, these data suggest that a majority of pre-school children maintain protective serotype-specific antibody concentrations following conjugate vaccination at 2, 4 and 12 months of age. Trial Registration: ClinicalTrials.gov NCT01095471 © 2014 Trück et al.

Cite

CITATION STYLE

APA

Trück, J., Snape, M. D., Tatangeli, F., Voysey, M., Yu, L. M., Faust, S. N., … Pollard, A. J. (2014). Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: Follow-up from a randomized controlled trial. PLoS ONE, 9(3). https://doi.org/10.1371/journal.pone.0091413

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free